China Commits To Patent Linkage And Extensions
Data Protection Also Included In Deal
The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.
You may also be interested in...
India and China have once again come under fire from the US over intellectual property protections, in the US Trade Representative’s latest “Special 301” report.
In a significant development, China proposes to strengthen the protection of new drugs through not only patent linkage but also patent compensation in the latest draft of its revised Patent Law.
The US Senate’s vote to approve legislation underpinning the US-Mexico-Canada trade agreement has been welcomed by the country’s off-patent industry.